Probe for diseases wth amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change

Details for Australian Patent Application No. 2004265174 (hide)

Owner BF Research Institute, Inc.

Inventors Suzuki, Masako; Shiomitsu, Tsuyoshi; Shimazu, Hiroshi; Kudo, Yukitsuka; Okamura, Nobuyuki; Suemoto, Takahiro

Agent Davies Collison Cave

Pub. Number AU-A-2004265174

PCT Pub. Number WO2005/016888

Priority PCT/JP03/15229 28.11.03 JP; 2003-293056 13.08.03 JP

Filing date 11 August 2004

Wipo publication date 24 February 2005

International Classifications

C07D 215/12 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4184 (2006.01)

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 235/06 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/48 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/57 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/64 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016888 Priority application(s): WO2005/016888

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004265182-Process for production of cis4-fluoro-L-proline derivatives

2004265173-Tubular reaction vessel and process for producing silicon therewith